SEC Form 4 · accession 0001677300-16-000005
Bausch Health Companies Inc. · BHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert N Power
Director
Period of report
Jun 17, 2016
Accepted (ET)
Jun 21, 2016 · 8:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885590
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par valueF1,F2 | Jun 17, 2016 | A | 16,726 | $0.00 | A | 32,822 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
- F2Regular annual RSUs equal to $375,000 granted to non-employee directors in office on the third trading day following the Annual Meeting of Shareholders. Pricing is based on the closing price of registrant common stock on the date prior to the grant.